Abstract-Within the life sciences switching mechanisms are pervasive at all levels, from molecules to cells and tissues. Their operation can be a key determinant of health or disease. Whilst the existence and importance of switches is widely acknowledged within the biological literature, many life scientists do not deal explicitly with the switching behaviour. Frequently, steady-state behaviour before and after switching is the primary focus. Here methods for analysis of switched systems from control engineering are applied to the modelling and analysis of a riboswitch. The model has been developed by studying the dynamics of the vitamin B12 riboswitch. The simulation results have been validated using in vivo experiments by checking the bacterial growth when using Escherichia coli and Salmonella enterica where the action of the vitamin B12 riboswitch is known to be a determinant of system behaviour. The paper first describes a simple model for the B12-riboswitch regulatory network in E. coli and applies the same analysis when changing the strain to S. enterica. Validation of the simulation results has been undertaken by linking the dynamics of the riboswitch to bacterial growth.
I. INTRODUCTION
Vitamin B 12 , the cyano-derivative of cobalamin, is a water-soluble vitamin whose biological forms play key roles in metabolism that affect the normal functioning of the brain and nervous system in humans. Herein, we use the term B 12 generically to refer to cobalamin. B 12 is unique among the vitamins in that it is made exclusively by only certain prokaryotes and there is significant interest in how B 12 production is controlled within microbial communities and how the nutrient makes its way through the food chain into animals. For humans B 12 deficiency is most often associated with an autoimmune disorder that prevents the body from absorbing the nutrient but people on a strictly vegetarian diet are also prone to deficiency as plants neither make nor require B 12 . In fact, dietary B 12 deficiency is a severe problem in many developing countries including the Indian subcontinent, Mexico, central and South America and selected areas of Africa [1] . Moreover, B 12 deficiency is also a common problem for the 115000 sufferers of Crohn's disease in the UK and millions more worldwide as the inflammation caused by the condition can affect the end of the ileum, which is the main area where B 12 is absorbed [2] . To understand the control of B 12 availability it is important to study the gene regulatory network (GRN), which is a collection of molecular regulators that interact with each uceemdo@ucl.ac.uk, s.spurgeon@ucl.ac.uk other and with other substances in the cell to govern the gene expression [3] . Riboswitches are naturally occurring RNA-based regulatory components that essentially function by first sensing specific metabolites such as cofactors, amino acids and nucleotides and then regulating the expression level of proteins in the corresponding metabolic pathways [4] . The switches undergo a conformational change in response to a small-molecule ligand whereby increasing ligand concentrations either increase or decrease gene expression. The steadily increasing number of examples of such natural RNA regulators that control gene expression through diverse mechanisms in different organisms has fostered growing interest in using RNA to build synthetic controllers. Both naturally occurring and synthetic riboswitches are seen to be highly tunable components capable of regulating gene expression. Some work to model riboswitch function has taken place and useful guidelines have been developed for tuning, but this work has been performed under steady-state operating conditions. The literature on the tuning of riboswitches also focusses primarily on the riboswitch as an individual element rather than as a component within a wider biological pathway [5] . The mathematical model which is used in this paper is based on the riboswitch regulatory pathway [3] . This riboswitch is capable, in principle, of regulating BtuB, which is an outer membrane porin that mediates high affinity binding and TonB-dependent active transport of vitamin B 12 across the outer membrane. Regulation at the transcriptional level occurs when a B 12 molecule binds the riboswitch aptamer domain and causes the formation of a terminator structure in the riboswitch expression platform. After estimating the parameters of the model, the system has been validated by creating an equation for the bacterial growth and it is proved experimentally that the model reproduces the system behaviour and captures the system dynamics within suitable bounds. For validation purposes, the growth levels in vitamin B 12 -dependent bacteria were determined when grown in environments containing different concentrations of vitamin B 12 . E. coli and S. enterica strains were used in the experiments and the growth levels were measured using optical density data recorded on triplicates at 600 nm. The verification process was performed by comparing simulation and experimental results. In addition, the assessment of the saturation effect when the concentration is high or low has been studied. The organisation of the paper is as follows: first, a preliminary analysis for the model of vitamin B 12 is conducted. Second, the model validation is undertaken and finally, a comparison between the analytical analysis and the experimental results is made.
II. ANALYSIS OF A SIMPLE MODEL OF THE VITAMIN B 12 RIBOSWITCH
The mathematical model which is used in this paper is based on the riboswitch regulatory pathway. Gene expression can be regulated at several levels in a cell. Differential gene transcription regulates which genes are allowed to be transcribed into RNA while selective nuclear RNA processing regulates which transcribed RNA can enter the cytoplasm and become messenger RNA. Genes can be regulated any time before, after or during the processes of translation and transcription. E. coli is incapable of synthesizing vitamin B 12 . Instead, these bacteria actively transport the vitamin from the environment. BtuB, which is encoded by gene btuB, is an important component of the vitamin B 12 transporter. Gene btuB is negatively regulated by vitamin B 12 via a riboswitch. To develop a mathematical model for the B 12 -riboswitch regulatory network in E. coli, Santillan et al. (2005) [3] identified three normalised model variables m, e and p which respectively represent the concentration of btuB mRNA , the concentration of BtuB and the concentration of vitamin B 12 . The model itself is described by:
(1)
The biological meaning of the parameters in (1) - (3) are shown in Table I . The functions φ(p) and θ(p) denote the B 12 -governed regulation at the transcriptional and translational levels respectively. These functions are shown to be given by the following Michaelis-Menten equations:
Santillan et al. [3] presents simulation results that have been undertaken for only 600 minutes, and the steady state value for the concentration of the vitamin B 12 is 1. When the simulation is run for a longer time (1500 minutes), the concentration of vitamin B 12 increases again after 900 minutes as shown in Fig. 1 . This is an unexpected response and does not match the expected experimental results because the system should switch off when the concentration goes to zero. The controls Φ(P ) and Θ(P ) in the Michaelis-Menten equations depend on the value of the concentration of vitamin B 12 , which is the third variable in the mathematical model (1) - (3) and thus the control system response is as shown in Fig. 1 . As this does not match the expected experimental results, the parameters of the mathematical model (1) - (3) need to be modified. In the original paper [3] , the dissociation constants at the transcription (K φ ) and translation (K θ ) levels are considered to be 1/4. Using this value, the steady-state value for the concentration will increase after 900 minutes. Based on the literature [8] , [9] the dissociation constant for the reaction has a smaller magnitude. By changing the dissociation constant to 2.25 × 10 −6 , the concentration output is correct and matches the results expected from experiments. The new parameter values are shown in Table I . The simulations using the modified parameters were carried out by solving (1) -(3) with MATLAB as shown in Fig. 2 . Initial conditions of the normalised concentration of btuB mRNA, the concentration of BtuB and the concentration of vitamin B 12 were chosen as m(0) = 1, e(0) = 1 and p(0) = 0. All the simulations shown in this study used the same initial conditions. It is recognised from the simulation results of model (1) 
using the steady-state value of m given by φ(p). There are several parameters that affect the reduced order mathematical model of the regulation equations for the B 12 riboswitch as shown in (4) - (5). These parameters are the BtuB degradation rate, the B 12 degradation rate and the value that is used to show which strain has been used ( ). The effect of varying these parameters on the concentration of vitamin B 12 and the bacterial growth rate will be considered.
III. MODEL VALIDATION
To validate the model, it is necessary to model the growth curve from (4) -(5) and compare it with the growth curve obtained from the experiments. The comparison will include different levels of vitamin B 12 concentration (50pM -1nM). The effect of the parameters will be described in detail. For example, the relation between the concentration of vitamin B 12 and the growth will be considered. Bacteria have three growth phases as shown in 
they require time to detect the environment, express specific genes, and synthesize components necessary for rapid growth. The cells are not dividing at this time. 2) Exponential (log) phase: binary fission occurs at a maximum rate, the cells are dividing as rapidly as possible. 3) Stationary phase: at this point, growth has stopped and there is no net increase or decrease in the number of cells. Bacteria use new forms of metabolism to survive in some cases producing secondary metabolites. A model incorporating the effect of varying concentration of vitamin B 12 with the OD600 bacterial growth output (which denotes the absorbance, or optical density, of a sample measured at a wavelength of 600 nm) is shown below: The initial number of bacteria, bacterial type and the experimental environment depends on the particular experimental conditions. Table II presents a set of parameters consistent with the experiments performed. This choice may be justified by considering Fig. 4 . P max is defined to be the maximum value of the concentration of vitamin B 12 and t s is defined to be the time at which the maximum is reached. These values have been computed directly from the model (4) -(5) and can also be identified from the experimental results. It is clear that P max and t s vary with the change of Btub degradation rate ξ. Figure 5 shows P max corresponding to different values of ξ. Changing the bacterial strain will also change P max and this is demonstrated both from simulation and experimental results as shown in Fig. 6 . Simulations were carried out by solving (4) - (5) and applying the simulation results in the growth equation. It is seen that by increasing the concentration of vitamin B 12 , the absorbance at OD600 will increase and the time required to reach the steady-state value will decrease. The time required to reach the stationary phase and the absorbance at OD600 for both simulation and experimental results for all concentrations is shown in Table  III and Table IV . Fig. 4 shows the experimentally measured growth curve of E. coli with varying B 12 concentration between 50pM and 1nM across three growth phases. In the lag phase, there is no change between the curves even when the concentration is changed. That is because the system requires time to detect the environment and synthesize components necessary for rapid growth while in the exponential phase. By changing the concentration of vitamin B 12 , the growth curve changes. From Fig. 4 , it is seen that the OD600 during the lag phase is 0.1 and t s is 400 minutes. These two values vary from one plate reader to another as they are dependent on the number of bacteria present when the experiment is initialised and the atmospheric conditions in the laboratory, which may change. The exponential phase starts from 400 minutes to reach t s . The value of t s has a negative relation with the concentration of vitamin B 12 , so when the concentration of vitamin B 12 increases, the value of t s decreases. In the stationary phase, the bacterial growth stops and there is no net increase or decrease in the number of cells. Varying the concentration of vitamin B 12 will change the steady state value of absorbance. For example, when the concentration of vitamin B 12 is 50pM, the value of absorbance at OD600 
IV. DISCUSSION
To validate the model, a comparison has been made between the experimental results and the simulation results as shown in Fig. 6 . Table III shows a comparison between the   TABLE III: Comparison between the time required to reach the stationary phase experimentally and the time required for the concentration to reach zero mathematically.
Concentration of Time required to reach Time required to reach
Vitamin B 12 the stationary phase the stationary phase in Fig. 6, 7 (mins) in Fig. 6 time required to reach the stationary phase in simulation and experimentally while varying the concentration of vitamin B 12 . It is clear that by increasing the concentration, growth is faster and it reaches the stationary phase more rapidly. In addition, by increasing the concentration the maximum value of the simulated concentration will increase and thus the absorbance at 600 nm will increase as shown in Table IV . Growth reaches the stationary phase when the concentration that has been used. Here, E. coli and S. enterica are used and they have different growth curves as shown in Fig. 6 . The experiments correspond to the wild-type E. coli and 375 mutant strain S. enterica [10] . The values of employed in these simulations are as follows: = 25 (wild-type strain), = 21.5 (375 mutant strain). The value of absorbance at OD600 increases when the value of increases. From Fig. 6 , the absorbance at OD600 is 0.63 when = 25 and it decreases to 0.52 when = 21.5.
After the model has been validated, an expected growth curve when the concentration of vitamin B 12 is 25pM has been generated based only on the mathematical model. Experimental results were then obtained to verify the predictions. Fig. 8 shows the comparison between the simulated and experimental growth curve for E. coli with a concentration of 25pM. The model parameter t l in (6) is zero and OD600 at the lag phase is 0.15. This setting is based on the plate that has been used for the experiments where it should be noted that results vary between plates.
It can be concluded that there is a positive relation between the concentration of vitamin B 12 and bacterial growth, as when the concentration of vitamin B 12 increases, the growth curve increases. Moreover, when the concentration of vitamin B 12 increases to a certain level, it should be noted that bacterial growth will saturate. Comparing simulation and experimental results, it can be seen that the value of the concentration when the growth saturates is 1 nM; increasing the concentration of vitamin B 12 by more than 1 nM, produces no change in the growth curve. Using the experimental results shown in Fig. 9a which are the experimental growth curve results for E. coli when the concentration of vitamin B 12 is between 1nM and 100 µM, the experimental results agreed with the observed simulation results. In addition, this shows that for all the concentrations (1nM -100 µM ), the bacterial growth curve is approximately the same. Fig.  9b shows the growth curve for E. coli when varying the concentration of vitamin B 12 between 1 pM and 10 fM. This also shows that when the growth is in the exponential phase, the growth is increasing slowly and the absorbance at OD600 is low. This also agrees with the simulation results, as when the concentration is low, the amplitude of the output is low. The growth curve remains in the exponential phase. When the concentration is decreased further, the absorbance at OD600 will also decrease to reach the same value as in the lag phase as shown in table V. 
V. CONCLUSIONS
In this paper, the effect of the vitamin B 12 riboswitch has been tested at both the cellular and population level. For the cellular level, the concentration of btub mRNA, the concentration of the BtuB and the concentration of vitamin B 12 have been studied to determine how they affect the cells during transcription and translation. The dynamics of the vitamin B 12 riboswitch have been incorporated in a model with E. coli bacterial growth. At the population level, the effect of varying the concentration of vitamin B 12 has been tested on the bacterial growth curves of E. coli. The same analysis has been performed with different bacterial strains. The effect of changing the concentration of vitamin B 12 in bacterium S. enterica has been tested. The results at both the cellular and population level have been linked and the simulation results obtained replicated the experimental results. The effect of enzyme inhibitors which are vitamin B 12 analogues will be considered in future work. The long term objective of the study is to provide modelling and simulation tools to assist in the study of the impact of the vitamin B 12 on health.
